For the quarter ending 2025-11-30, CBIH made $53,266 in revenue. -$116,966 in net income. Net profit margin of -219.59%.
| Income Statement | 2025-11-30 | 2025-08-31 | 2025-05-31 | 2024-11-30 |
|---|---|---|---|---|
| Revenues | 53,266 | 24,200 | 24,943.5 | 74,248 |
| Cost of revenues | 10,500 | 8,143 | 11,970.5 | 7,803 |
| Gross profit | 42,766 | 16,057 | 12,973 | 66,445 |
| General and administrative | 30,972 | 23,308 | 241 | 40,128 |
| Contract labor | 36,141 | 42,520 | 37,625.5 | 54,296 |
| Professional fees | 52,035 | 7,741 | 86,727.5 | 7,112 |
| Officer compensation | 8,094 | 6,000 | 6,000 | 6,000 |
| Share-based compensation | - | 0 | - | - |
| Rent and lease | 11,339 | 11,059 | 14,307 | 18,439 |
| Travel | 62 | 213 | 139 | 97 |
| Total operating expenses | 138,643 | 90,841 | 145,040 | 126,072 |
| Operating loss | -95,877 | -74,784 | -132,067 | -59,627 |
| Amortization of discount | 0 | 19,815 | 11,038.5 | - |
| Note discount expense | 3,230 | - | -3,733.333 | 11,200 |
| Forgiveness of debt | 0 | 0 | 0 | - |
| Change in fair value of derivative liabilities | 0 | 29,322 | 7,330.75 | - |
| Interest | 17,860 | 17,368 | 62,611 | 8,701 |
| Total other income (expense) | -21,090 | -7,861 | -64,426.5 | -19,901 |
| Net loss | -116,966 | -82,645 | -196,493.5 | -79,528 |
| Average common stock outstanding, basic | 11,626,749,347 | 11,626,749,347 | -5,120,015,451.5 | 10,497,459,730 |
| Average common stock outstanding, diluted | 11,626,749,347 | 11,626,749,347 | -5,120,015,451.5 | 10,497,459,730 |
| Average earnings (loss) per share, basic | -0 | -0 | -0 | -0 |
| Average earnings (loss) per share, diluted | -0 | -0 | -0 | -0 |
Cannabis Bioscience International Holdings, Inc. (CBIH)
Cannabis Bioscience International Holdings, Inc. (CBIH)